Bank of New York Mellon Corp - ONCOSEC MED INC ownership

ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 35 filers reported holding ONCOSEC MED INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ONCOSEC MED INC
ValueSharesWeighting
Q3 2022$187,000
-34.4%
383,4910.0%0.00%
Q2 2022$285,000
-35.8%
383,491
-0.7%
0.00%
Q1 2022$444,000
+806.1%
386,074
+653.7%
0.00%
Q4 2021$49,000
-55.0%
51,2250.0%0.00%
Q3 2021$109,00051,2250.00%
Other shareholders
ONCOSEC MED INC shareholders Q3 2021
NameSharesValueWeighting ↓
SALZHAUER MICHAEL 277,312$591,0000.24%
Avidity Partners Management LP 2,945,000$6,273,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 316,229$674,0000.12%
J. Goldman & Co LP 790,242$1,683,0000.08%
Sandbox Financial Partners, LLC 25,000$53,0000.04%
Virtu Financial LLC 25,166$54,0000.01%
D.A. DAVIDSON & CO. 108,500$231,0000.00%
J. Goldman & Co LP 26,300$56,0000.00%
TWO SIGMA ADVISERS, LP 361,401$770,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 49,500$105,0000.00%
View complete list of ONCOSEC MED INC shareholders